Creating New Models to Combat Neglected Disease Through, Industry, Government, and Public-Private Partnerships

April 5, 2018 @ 2-3pm ET

Green Forest in background with white symbols of academic cap, government building, and private industry building

Neglected tropical diseases represent a mostly unprofitable area for drug discovery research. As a result, the drug industry doesn’t usually approach this work solely using internal resources. Similarly, academic laboratories do not frequently have the depth and breadth of knowledge and experience in drug discovery. Join Michael Pollastri, Professor and Chair of Chemistry and Chemical Biology at Northeastern University, as he discusses a successful model of distributed neglected tropical disease drug discovery that involves collaborators in industry, government, and public-private partnerships.

What You Will Learn

  • What are neglected tropical diseases, what are the challenges for discovering new medicines, and why it’s essential that we pay close attention to them
  • A streamlined method for hit- and lead-discovery that leverages existing drugs and clinical candidates and repurposes them for NTD drug discovery
  • How to connect laboratories in academia, industry, government, and public-private partnerships in order to accomplish goals

The Fine Print

ACS Webinars® does not endorse any products or services. The views expressed in this presentation are those of the presenters and do not necessarily reflect the views or policies of the American Chemical Society.

ACS Webinars Logo


Michael Pollastri
Northeastern University

Félix Calderón

Co-produced with

Benefits of Membership

  • ACS Webinars Archive: Every one of our 200+ past webinars available on demand
  • Save Money: Members receive discounts on meetings, development courses and more!
  • Access to SciFinder®: Members receive 25 complimentary SciFinder® research activities per year